CIK 0001811063
- Non-accelerated filer
- Smaller reporting company
Nuvation Bio Inc.
Sign in to watch- Ticker
- NUVB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 850862255
- Phone
- +1 332-208-6102
- Business address
- 1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
- Former names
- Panacea Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-28 | Fox Jennifer A. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +600,000 | 600,000 | ||
| 2022-08-29 | Fox Jennifer A. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +480,000 | 480,000 | ||
| 2022-02-28 | Fox Jennifer A. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +600,000 | 600,000 | ||
| 2021-02-10 | Fox Jennifer A. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +398,935 | 398,935 | ||
| 2021-02-10 | Fox Jennifer A. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +558,506 | 558,506 |
Page 1 of 1 · 5 trades